Dubai - CelltraZone signed an exclusive distribution agreement with the AGBL Group (Dubai, UAE) to bring their innovative Liquid-Based Cytology Slide Processors to the MEA markets.
"CelltraZone’ s patented solutions and filters will allow pathologists to have a higher quality smears for diagnosis of cancer cells in Gynaecological and Non-Gynaecological samples, we think it will be a great addition to our laboratories in the region", said Nisreen Haddadin, Product Manager at Alliance Global.
About CelltraZone
CelltraZone is a Korean company, established in 2007 as the manufacturer of Liquid Base Cytology (LBC) Systems. CelltraZone is focusing all their efforts toward contributing to the health of people through supplying advanced products of high quality in the cytological diagnosis field. CelltraZone have succeeded in achieving the high qualities of smearing with speed, convenience and simplicity of processing and compactness of the processor with very low prices. All CelltraZone products are manufactured and supplied within the framework of a Quality Management System accredited to EN ISO 13485:2012.
More information is available at- http://www.celltrazone.com
About Alliance Global Group (AGBL)
The AGBL Group of companies is the largest biomedical gateway to the emerging markets of the Middle East, Africa and Asia. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the emerging healthcare markets within the MEAA region. The group's stated mission is to improve the lives of the region's inhabitants through novel biomedical technologies and products. For more information, please visit: www.agbl.net
© Press Release 2017
